BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 32886697)

  • 21. Role of the IL-33/ST2 axis in cardiovascular disease: A systematic review and meta-analysis.
    Sun Y; Pavey H; Wilkinson I; Fisk M
    PLoS One; 2021; 16(11):e0259026. PubMed ID: 34723980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of heart failure and adverse cardiovascular events in outpatients with coronary artery disease using mitral E/A ratio in conjunction with e-wave deceleration time: the heart and soul study.
    Mishra RK; Devereux RB; Cohen BE; Whooley MA; Schiller NB
    J Am Soc Echocardiogr; 2011 Oct; 24(10):1134-40. PubMed ID: 21764551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term and Short-Term Prognostic Value of Circulating Soluble Suppression of Tumorigenicity-2 Concentration in Chronic Heart Failure: A Systematic Review and Meta-Analysis.
    Dong G; Chen H; Zhang H; Gu Y
    Cardiology; 2021; 146(4):433-440. PubMed ID: 33902050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Significance of Triglyceride-Glucose Index for Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Luo JW; Duan WH; Yu YQ; Song L; Shi DZ
    Front Cardiovasc Med; 2021; 8():774781. PubMed ID: 34926622
    [No Abstract]   [Full Text] [Related]  

  • 25. Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure.
    Tang WH; Wu Y; Grodin JL; Hsu AP; Hernandez AF; Butler J; Metra M; Voors AA; Felker GM; Troughton RW; Mills RM; McMurray JJ; Armstrong PW; O'Connor CM; Starling RC
    JACC Heart Fail; 2016 Jan; 4(1):68-77. PubMed ID: 26656144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison Between Soluble ST2 and High-Sensitivity Troponin I in Predicting Short-Term Mortality for Patients Presenting to the Emergency Department With Chest Pain.
    Marino R; Magrini L; Orsini F; Russo V; Cardelli P; Salerno G; Hur M; Di Somma S;
    Ann Lab Med; 2017 Mar; 37(2):137-146. PubMed ID: 28029000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble ST2 in Patients with Carotid Artery Stenosis-Association with Plaque Morphology and Long-Term Outcome.
    Stojkovic S; Kampf S; Harkot O; Nackenhorst M; Brekalo M; Huber K; Hengstenberg C; Neumayer C; Wojta J; Demyanets S
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of soluble ST2 biomarker in heart failure patients with reduced ejection fraction - A multicenter study.
    Bahuleyan CG; Alummoottil GK; Abdullakutty J; Lordson AJ; Babu S; Krishnakumar VV; Pillai AM; Abraham G; Dilip MN
    Indian Heart J; 2018 Jul; 70 Suppl 1(Suppl 1):S79-S84. PubMed ID: 30122243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognosis in relation to high-sensitivity cardiac troponin T levels in patients with myocardial infarction and non-obstructive coronary arteries.
    Hjort M; Lindahl B; Baron T; Jernberg T; Tornvall P; Eggers KM
    Am Heart J; 2018 Jun; 200():60-66. PubMed ID: 29898850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib-Thrombolysis in Myocardial Infarction 52) Trial.
    Fanola CL; Morrow DA; Cannon CP; Jarolim P; Lukas MA; Bode C; Hochman JS; Goodrich EL; Braunwald E; O'Donoghue ML
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. sST2 as a New Biomarker of Chronic Kidney Disease-Induced Cardiac Remodeling: Impact on Risk Prediction.
    Plawecki M; Morena M; Kuster N; Chenine L; Leray-Moragues H; Jover B; Fesler P; Lotierzo M; Dupuy AM; Klouche K; Cristol JP
    Mediators Inflamm; 2018; 2018():3952526. PubMed ID: 30402040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarkers as predictors of sudden cardiac death in coronary artery disease patients with preserved left ventricular function (ARTEMIS study).
    Lepojärvi ES; Huikuri HV; Piira OP; Kiviniemi AM; Miettinen JA; Kenttä T; Ukkola O; Perkiömäki JS; Tulppo MP; Junttila MJ
    PLoS One; 2018; 13(9):e0203363. PubMed ID: 30226845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study.
    Brozaitiene J; Mickuviene N; Podlipskyte A; Burkauskas J; Bunevicius R
    BMC Cardiovasc Disord; 2016 Feb; 16():45. PubMed ID: 26892923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of plasma soluble suppression of tumorigenicity-2 level with the severity and stability of coronary atherosclerosis.
    Zhang Y; Fan Z; Liu H; Ma J; Zhang M
    Coron Artery Dis; 2020 Nov; 31(7):628-635. PubMed ID: 32040025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL1RL1 single nucleotide polymorphism predicts sST2 level and mortality in coronary and peripheral artery disease.
    Lin JF; Wu S; Juang JJ; Chiang FT; Hsu LA; Teng MS; Cheng ST; Huang HL; Sun YC; Liu PY; Ko YL
    Atherosclerosis; 2017 Feb; 257():71-77. PubMed ID: 28110258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Soluble ST2 Serum Levels With Outcomes in Pediatric Dilated Cardiomyopathy.
    You H; Jiang W; Jiao M; Wang X; Jia L; You S; Li Y; Wen H; Jiang H; Yuan H; Huang J; Qiao B; Yang Y; Jin M; Wang Y; Du J
    Can J Cardiol; 2019 Jun; 35(6):727-735. PubMed ID: 31151708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of fasting blood glucose to high-density lipoprotein cholesterol ratio with short-term outcomes in patients with acute coronary syndrome.
    Deng S; Wang Z; Zhang Y; Xin Y; Zeng C; Hu X
    Lipids Health Dis; 2022 Jan; 21(1):17. PubMed ID: 35094695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive values of sST2 and IL-33 for heart failure in patients with acute myocardial infarction.
    Xing J; Liu J; Geng T
    Exp Biol Med (Maywood); 2021 Dec; 246(23):2480-2486. PubMed ID: 34342552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Soluble Suppression of Tumorogenicity 2 Increases Opportunities for Risk Stratification After Acute Heart Failure Decompensation].
    Skvortsov AA; Protasov VN; Narusov OY; Koshkina DE; Nasonova SN; Masenko VP; Tereschenko SN
    Kardiologiia; 2017 Jan; (1):48-58. PubMed ID: 28290833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of galectin-3 and soluble ST2 with in-hospital and 1-year outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Tymińska A; Kapłon-Cieślicka A; Ozierański K; Budnik M; Wancerz A; Sypień P; Peller M; Maksym J; Balsam P; Opolski G; Filipiak KJ
    Pol Arch Intern Med; 2019 Nov; 129(11):770-780. PubMed ID: 31642446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.